Skip to content

Effect of pulmonary tele-rehabilitation and progressive muscle relaxation training in COVID-19 patients

Evaluation of the effect of pulmonary tele-rehabilitation with and without progressive muscle relaxation training on exercise capacity, anxiety and depression in COVID-19 patients after hospital discharge: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140810018754N12
Enrollment
52
Registered
2021-03-15
Start date
2021-02-08
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: pulmonary telerehabilition with progressive muscle relaxation exercise. pulmonary rehabilitation includes breathing exercises, aerobic and resistance exercises. The

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: COVID-19 confirmed with polymerase chain reaction test (PCR) Discharged from hospital (at least six days after the onset of symptoms) Patients who have to the ability to read and write in Persian Patients who access to the Internet and video call service

Exclusion criteria

Exclusion criteria: Severe heart condition such as uncontrolled arrhythmias Chronic pulmonary and kidney condition Severe neurological condition such as guillan-barre, stroke and multiple sclerosis Uncontrolled diabetes or hypertension Smoker Athlete Pregnant women

Design outcomes

Primary

MeasureTime frame
Exercise capacity. Timepoint: before intervention, up to two and six week after intervention. Method of measurement: Six minute walk test.

Secondary

MeasureTime frame
Dyspnea. Timepoint: Before intervention, up to two and six week after start of intervention. Method of measurement: 0-10 dyspnea Borg scale.;Axiety. Timepoint: Before intervention and six weeks after start of intervention. Method of measurement: Hospital anxiety and depression scale.;Sleep quality. Timepoint: Before intervention, six weeks after start of intervention. Method of measurement: Petersborg sleep quality questionaire.;Quality of life. Timepoint: Before intervention, six weeks after start of intervention. Method of measurement: SF36, santgeorg respiratory questionaire.;Fatigue severity. Timepoint: Before intervention, six weeks after start of intervention. Method of measurement: fatigue severity scale.;Exercise capacity. Timepoint: Before intervention, six weeks after start of intervention. Method of measurement: repeated chair rise test during 30 seconds.;Depression. Timepoint: Before intervention and six weeks after start of intervention. Method of measurement: Hospital anxiety and depression scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Sarrafzadeh

Iran University of Medical Sciences

sarrafzadeh.j@iums.ac.ir00982122228051-00982122227124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026